Skip to content
BioSignal
Condition

Uterine Fibroids

Extremely common, almost never cancer — and treated far too readily with a hysterectomy

Last reviewed
July 2026
Version
1.0
Review cadence
Annually

What it is

Uterine fibroids (leiomyomas) are benign growths of the muscular wall of the uterus. They are extraordinarily common: by the age of 50, a majority of women will have had them, and most will never know. They are not cancer, and — this is the fact that reassures people most and is told to them least — they do not turn into cancer. When they do cause symptoms, it is the LOCATION rather than the size that determines what happens: a small fibroid pressing into the cavity of the uterus can cause torrential bleeding, while a large one on the outer surface may cause nothing but a sensation of pressure.

Why it matters

Because fibroids are the reason for an enormous number of hysterectomies, and a great many of them are avoidable. The treatment options are broad — medical, radiological, and conservative surgical — and the option a person is offered depends heavily on who they happen to see. There is also a genuine and under-acknowledged inequity here that BioSignal will state rather than skate over: BLACK WOMEN DEVELOP FIBROIDS EARLIER, MORE OFTEN, AND MORE SEVERELY, and are more likely to undergo hysterectomy rather than uterus-preserving treatment. That disparity is well documented, poorly explained, and under-researched, and it is not something to leave out of a page about fibroids.

The evidence

What BioSignal knows about treating this

Guideline-anchored clinical contextLast reviewed July 2026 · reviewed annually · 4 references

What works for Uterine Fibroids

BioSignal’s clinical summary, most important first.

  1. IF THEY ARE NOT CAUSING SYMPTOMS, DO NOTHING — most fibroids need no treatment at all, and finding one on a scan is not by itself a reason to act. They typically shrink after the menopause
  2. TREAT THE SYMPTOM, NOT THE SCAN — the question is never 'is there a fibroid', it is 'is this fibroid causing this problem'
  3. Tranexamic acid and NSAIDs for bleeding — non-hormonal, effective, and often not offered
  4. The levonorgestrel intrauterine system — effective for bleeding, provided the fibroid has not distorted the uterine cavity
  5. GnRH analogues — shrink fibroids temporarily; used mainly before surgery, as the effect reverses on stopping
  6. Uterine artery embolisation — a radiological procedure that shrinks fibroids while preserving the uterus. A genuine alternative to surgery that many people are never told about
  7. MYOMECTOMY — surgical removal of the fibroid with the uterus left in place. The uterus-preserving option, and the one to ask about explicitly if fertility matters or if you simply want to keep your uterus
  8. Hysterectomy — definitive, and a LAST resort. Ask what the uterus-preserving alternatives are before agreeing to it, and ask again if the answer comes quickly
  9. Correct the iron deficiency — fibroid-related bleeding is a leading cause of it, and treating the iron without treating the bleeding is a treadmill

Signal Records relevant to this condition

Interventions and contributing factors — some of these records describe a cause rather than a cure. The rating shown is BioSignal’s confidence in that Signal Record, not a claim about how well it treats this condition. Open any of them for the full evidence.

Start Here

New to this? Read these first

  1. FoundationHormonal HealthHow to read hormones properly — and why both over-treatment and under-treatment cause harm.
  2. BiomarkerFerritinIron stores — with an inflammation caveat
  3. Signal RecordVitamin DCholecalciferol (Vitamin D₃)
  4. Body SystemHormonesEndocrine signaling that regulates the whole body.
  5. ConditionHeavy Menstrual BleedingNot something to put up with — and sometimes a bleeding disorder nobody looked for
Typical Journey

How this usually unfolds

  1. Recognize risk factors
  2. Get diagnosed
  3. Track key biomarkers
  4. Lifestyle first
  5. Evidence-based treatment
  6. Long-term monitoring

An orientation to how this topic is typically approached — not medical advice.

Who is at risk

  • Black ethnicity — 2–3 times the incidence, earlier onset, larger and more numerous fibroids, and more severe symptoms. Well documented, poorly explained, and under-researched
  • Age — incidence rises through the reproductive years and fibroids typically shrink after the menopause
  • Family history
  • Obesity
  • Nulliparity
  • Early menarche

How it's diagnosed

Fibroids are usually found on pelvic ultrasound, either because someone presented with heavy bleeding, pressure symptoms or pain, or incidentally. The important part of the assessment is not that a fibroid exists — many do — but whether it explains the symptoms, and WHERE it sits. Submucosal fibroids, which protrude into the cavity of the uterus, cause bleeding out of all proportion to their size and are the ones most likely to affect fertility. Intramural and subserosal fibroids more often cause bulk symptoms: pressure, urinary frequency, constipation, and a distended abdomen. Rapid growth, or new symptoms after the menopause, warrants prompt assessment — not because fibroids become cancer, but because a rare separate cancer (leiomyosarcoma) can present in a similar way.

  • Pelvic ultrasound — the primary investigation, identifying number, size and crucially LOCATION
  • MRI — for surgical planning, or where ultrasound is inconclusive
  • Hysteroscopy — to see and often treat submucosal fibroids within the cavity
  • Ferritin and full blood count — heavy bleeding from fibroids causes iron deficiency, routinely
  • NOTE: rapid growth or new symptoms after menopause warrants prompt assessment. Fibroids do NOT become cancer, but the rare leiomyosarcoma can present similarly
Most important

Key biomarkers

FerritinHigh-Sensitivity CRP
Day to day

Lifestyle

  • Nothing in the diet or supplement aisle shrinks a fibroid, and a great deal is sold on the claim that it does
  • Manage the iron: heavy bleeding from fibroids is a leading cause of iron deficiency
  • Fibroids typically shrink after the menopause — which is relevant information if you are close to it and weighing surgery
Explore

Explore this condition across BioSignal

Related Foundations

Hormonal Health

Related Signal Records

Vitamin D

Related body systems

Hormones

Related conditions

Heavy Menstrual BleedingIron Deficiency & AnaemiaEndometriosisInfertilityMenopauseFatigue

Frequently asked questions

Are fibroids cancer? Can they become cancer?

No, and no — and this is the reassurance people most need and least often receive. Fibroids are benign growths of uterine muscle. They are not cancer, and a benign fibroid does not transform into one. There is a rare, separate cancer of uterine muscle called leiomyosarcoma, which is a different disease that arises on its own rather than from an existing fibroid. It is uncommon. What it means practically is only this: rapid growth, or new symptoms after the menopause, should be assessed promptly — not because your fibroid is turning into something, but because a different thing can present in a similar way.

Do I need a hysterectomy?

Very probably not, and you should ask hard before accepting one. Fibroids are among the commonest reasons hysterectomies are performed, and a large share of them are avoidable. There is a ladder of options below it: tranexamic acid and NSAIDs for bleeding; the hormonal coil; uterine artery embolisation, which shrinks the fibroids while keeping the uterus; and MYOMECTOMY, which removes the fibroid and leaves the uterus in place. If hysterectomy is offered quickly, the right question is: 'What are the uterus-preserving options, and why are they not right for me?' A good answer to that question exists in some cases. It should be given, not assumed.

My fibroid is huge but I feel fine. Do I need it removed?

Not necessarily, and size alone is a poor guide. Symptoms track LOCATION far more than size: a small fibroid pushing into the cavity of the uterus can cause torrential bleeding, while a large one sitting on the outer surface may cause nothing but a feeling of pressure. Asymptomatic fibroids often need no treatment at all, and they typically shrink after the menopause. The question is not how big it is. It is what it is doing to you.

Why are fibroids so much more common in Black women?

The disparity is real, large and well documented — Black women develop fibroids roughly two to three times as often, earlier in life, with larger and more numerous fibroids and more severe symptoms — and it is poorly explained. Genetic, vitamin D, and environmental factors have all been proposed and none fully accounts for it. What is better established, and more actionable, is that Black women with fibroids are more likely to receive a hysterectomy rather than a uterus-preserving treatment. That is not a biological finding. It is a treatment-pattern finding, and it is a reason to ask explicitly about myomectomy and embolisation.

Will fibroids stop me getting pregnant?

Most will not. It depends heavily on location: SUBMUCOSAL fibroids — the ones protruding into the cavity of the uterus — are the ones most clearly associated with reduced fertility and with miscarriage, and removing them appears to help. Fibroids in the wall or on the outer surface are far less likely to be the problem, and the evidence for removing them to improve fertility is much weaker. So the answer depends entirely on where yours is, which is exactly what the ultrasound is for.

Evidence summary

Uterine fibroids are benign monoclonal smooth muscle tumours of the myometrium and are extremely common, with cumulative incidence approaching or exceeding 70% by age 50 in some populations. Most are asymptomatic. Symptoms — heavy menstrual bleeding, bulk and pressure effects, and in some cases subfertility — correlate more strongly with location than with size, submucosal fibroids being the most likely to cause bleeding and to affect fertility and miscarriage risk. Incidence, age of onset and severity are substantially greater in Black women, a disparity that is well documented and not fully explained, and which is compounded by a higher rate of hysterectomy relative to uterus-preserving treatment. Benign fibroids do not undergo malignant transformation; leiomyosarcoma is a rare, distinct entity. Effective management options include tranexamic acid and NSAIDs, the levonorgestrel intrauterine system where the cavity is undistorted, GnRH analogues (temporarily, pre-operatively), uterine artery embolisation, myomectomy, and hysterectomy. Fibroids typically regress after menopause. No dietary or supplement intervention has been shown to shrink fibroids.

References & sources

  • NICE NG88 — Heavy menstrual bleeding (fibroid management)
  • ACOG practice bulletins on the management of uterine fibroids
  • Epidemiological studies of fibroid incidence and severity by ethnicity
  • Randomized and comparative studies of uterine artery embolisation versus surgery

Educational information — not medical advice

Condition pages orient you across the evidence; they don't diagnose or treat. Diagnosis and management belong with a qualified clinician. See our Medical Disclaimer.

Is this condition page clear, accurate, and useful? Your feedback shapes what we review next.

Give feedback